| Q51124538 | A single intraseptal injection of nerve growth factor facilitates radial maze performance following damage to the medial septum in rats |
| Q34160761 | Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies |
| Q42457798 | Antibody to NGF inhibits collateral sprouting of septohippocampal fibers following entorhinal cortex lesion in adult rats |
| Q33939448 | BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype |
| Q34351483 | Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery |
| Q40883694 | Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions |
| Q48859687 | Differential sprouting responses in axonal fiber systems in the dentate gyrus following lesions of the perforant path in WLDs mutant mice |
| Q40860852 | Effects of cholinergic deafferentation and NGF on brain electrical coherence |
| Q42506735 | Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor |
| Q48389059 | Effects of elevated levels of nerve growth factor on the septohippocampal system in transgenic mice |
| Q41137321 | Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates |
| Q40418117 | Induction of non-catalytic TrkB neurotrophin receptors during lesion-induced synaptic rearrangement in the adult rat hippocampus |
| Q40750474 | Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. |
| Q47689049 | Muscarinic therapies in Alzheimer's disease; from palliative treatments to disease modification |
| Q48508216 | Nerve growth factor and septal grafts: a study of behavioral recovery following partial damage to the septum in rats |
| Q36020790 | Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity |
| Q40912774 | Pharmacology of nerve growth factor in the brain |
| Q33749480 | Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases |
| Q33223647 | Pure Schwann cell suspension grafts promote regeneration of the lesioned septo-hippocampal cholinergic pathway |
| Q46288568 | Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain |
| Q42442034 | Recovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression |
| Q46449556 | Short-term and complete reversal of NGF effects in rats with lesions of the nucleus basalis magnocellularis |
| Q33961288 | The cholinergic neuronal phenotype in Alzheimer's disease |
| Q74697359 | The role of neuronal growth factors in neurodegenerative disorders of the human brain |
| Q33939094 | Trophic effects of purines in neurons and glial cells. |